The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Nicola Hulme
Advertisement
Nicola Hulme is a senior research scientist, Bristol Myers Squibb, UK, [email protected]
Articles by Nicola Hulme
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
3
Sustainability by Design: Re-Imagining Amorphous Dispersion Manufacturing
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5